NO20064053L - Androgen reseptormodulatorer - Google Patents

Androgen reseptormodulatorer

Info

Publication number
NO20064053L
NO20064053L NO20064053A NO20064053A NO20064053L NO 20064053 L NO20064053 L NO 20064053L NO 20064053 A NO20064053 A NO 20064053A NO 20064053 A NO20064053 A NO 20064053A NO 20064053 L NO20064053 L NO 20064053L
Authority
NO
Norway
Prior art keywords
androgen receptor
receptor modulators
modulators
benzonitriles
androgenic
Prior art date
Application number
NO20064053A
Other languages
English (en)
Norwegian (no)
Inventor
Lain-Yen Hu
Bruce Allen Lefker
Huangshu Lei
Daniel Yunlong Du
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20064053L publication Critical patent/NO20064053L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
NO20064053A 2004-02-13 2006-09-08 Androgen reseptormodulatorer NO20064053L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54473804P 2004-02-13 2004-02-13
US60564704P 2004-08-30 2004-08-30
PCT/IB2005/000229 WO2005080320A1 (en) 2004-02-13 2005-01-31 Androgen receptor modulators

Publications (1)

Publication Number Publication Date
NO20064053L true NO20064053L (no) 2006-11-08

Family

ID=34890476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064053A NO20064053L (no) 2004-02-13 2006-09-08 Androgen reseptormodulatorer

Country Status (20)

Country Link
US (1) US7576128B2 (es)
EP (1) EP1716110A1 (es)
JP (1) JP3997255B2 (es)
KR (1) KR100783255B1 (es)
AP (1) AP2006003700A0 (es)
AR (1) AR047606A1 (es)
AU (1) AU2005214167B2 (es)
BR (1) BRPI0507670A (es)
CA (1) CA2554696C (es)
CR (1) CR8555A (es)
EA (1) EA009902B1 (es)
EC (1) ECSP066761A (es)
IL (1) IL176935A0 (es)
MA (1) MA28361A1 (es)
NO (1) NO20064053L (es)
PA (1) PA8623501A1 (es)
PE (1) PE20051168A1 (es)
TW (1) TW200534842A (es)
UY (1) UY28746A1 (es)
WO (1) WO2005080320A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0509759A (pt) 2004-04-13 2007-10-16 Warner Lambert Co moduladores de androgênio
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
WO2006006065A1 (en) * 2004-07-08 2006-01-19 Warner-Lambert Company Llc Androgen modulators
CA2573457A1 (en) * 2004-08-18 2006-02-23 Warner-Lambert Company Llc 4-(2-methoxy-phenoxy)-2-trifluoromethyl-benzonitrile as an androgen modulator
US20070207987A1 (en) * 2004-08-31 2007-09-06 Warner-Lambert Company Llc Androgen Modulators
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
TW200708499A (en) * 2005-06-22 2007-03-01 Warner Lambert Co Process for producing ethers
WO2007007149A1 (en) * 2005-07-12 2007-01-18 Warner-Lambert Company Llc Androgen modulators
US20090170886A1 (en) * 2005-08-08 2009-07-02 Pfizer Inc Androgen modulators
EP3108879A1 (en) * 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
EP3833343B1 (en) * 2018-08-07 2024-02-21 Emory University Heterocyclic flavone derivatives, compositions, and methods related thereto

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE298470C (es)
US6124343A (en) * 1919-01-27 2000-09-26 Rhone-Poulenc Rorer Limited Substituted phenyl compounds with a substituent having a thienyl ring
US3535365A (en) * 1967-11-29 1970-10-20 Merck & Co Inc Preparation of 2,6-dichloro-4-methoxy-benzonitrile
DE2062349A1 (de) 1970-12-18 1972-06-29 Farbenfabriken Bayer Ag, 5090 Leverkusen Aminoaryloxy-ary!carbonsäurenitrile und ein Verfahren zu ihrer Herstellung
SU469247A3 (ru) 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
US4029493A (en) 1973-02-23 1977-06-14 Mobil Oil Corporation Substituted phenoxybenzonitriles as herbicides
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
FR2397387A1 (fr) * 1976-04-27 1979-02-09 Serobiologiques Lab Sa 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
DE2862100D1 (en) 1977-10-12 1983-01-05 Ici Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
DD150456A5 (de) 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4567201A (en) 1981-11-25 1986-01-28 Takeda Chemical Industries, Ltd. Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof
GB8504093D0 (en) 1985-02-18 1985-03-20 Ici Plc Alkene alkyne/cycloalkylene derivatives
LU88769I2 (fr) 1982-07-23 1996-11-05 Zeneca Ltd Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
EP0107759B1 (de) 1982-08-26 1992-12-16 MERCK PATENT GmbH Cyclohexanderivate und ihre Verwendung als Komponenten Flüssigkristalliner-Dielektrika
JPS59144747A (ja) 1983-02-04 1984-08-18 Chisso Corp ２−クロロ−４−アルキルオキシベンゾニトリル化合物
US4536321A (en) 1983-02-18 1985-08-20 Chisso Corporation Fluorobenzene derivatives and liquid crystal compositions containing the same
DE3515633A1 (de) 1985-05-02 1986-11-06 Merck Patent Gmbh, 6100 Darmstadt Benzonitrile
IL80186A (en) 1985-10-01 1990-09-17 Ciba Geigy Pyridinyl derivatives,their preparation and their use as microbicides
JPS63141967A (ja) 1986-11-21 1988-06-14 エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド 抗アレルギー薬として有用な１−アリールオキシー４−［（４−アリール）−１−ピペラジニル］−２−ブタノール
JPS63227502A (ja) 1987-03-17 1988-09-21 Sds Biotech Kk 防菌防カビ剤
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
US4925590A (en) * 1988-03-10 1990-05-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Derivatives of 4-cyano-2,3-difluorophenol
DE3825170A1 (de) 1988-07-23 1990-01-25 Hoechst Ag Substituierte 5-(4-(4,5-dihydro-2-oxazolyl)-phenoxyalkylenoxyalkyl)-isoxazole, verfahren sowie 5-(phenoxyalkylenoxyalkyl)-isoxazole als zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von krankheiten, die durch infektion mit viren hervorgerufen wurden
PT94954A (pt) 1989-08-10 1991-04-18 Glaxo Inc., Processo para a preparacao de derivados de piridazinona
US5051431A (en) 1989-09-22 1991-09-24 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
DE4017019A1 (de) 1990-05-26 1991-11-28 Hoechst Ag Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen
JPH04124183A (ja) 1990-09-14 1992-04-24 Mitsubishi Rayon Co Ltd 光学活性パントラクトン誘導体
GB9025828D0 (en) 1990-11-28 1991-01-09 Shell Int Research Herbicidal carboxamide derivatives
JP3088777B2 (ja) 1991-03-27 2000-09-18 富士薬品工業株式会社 新規光学分割剤及びそれを用いる光学活性アミンの製造方法
US5320825A (en) 1991-05-01 1994-06-14 Trustees Of The University Of Pennsylvania Serotonin reuptake inhibitors for S.P.E.C.T. imaging
JP3151929B2 (ja) 1992-05-15 2001-04-03 大日本インキ化学工業株式会社 フルオロシクロヘキセン誘導体
DE4217928A1 (de) 1992-05-30 1993-12-02 Hoechst Ag Neue Mischungen aus Herbiziden und Antidots, neue (Hetero-)Aryloxy-Verbindungen, Verfahren zu deren Herstellung, diese enthaltenden Mittel und deren Verwendung
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
WO1994005153A1 (en) 1992-09-09 1994-03-17 E.I. Du Pont De Nemours And Company Herbicidal benzene compounds
US5455274A (en) 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
GB2278054A (en) 1993-05-18 1994-11-23 Zeneca Ltd Compounds for the treatment of urinary incontinence
GB9321162D0 (en) 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
DE4339863A1 (de) 1993-11-23 1995-05-24 Bayer Ag Substituierte Carbamoyltriazole
TW262553B (es) 1994-03-17 1995-11-11 Hitachi Seisakusyo Kk
EP0756497A1 (en) 1994-04-21 1997-02-05 Nycomed Imaging As X-ray contrast compositions containing pharmaceutically acceptable clays
JPH07309850A (ja) 1994-05-16 1995-11-28 Canon Inc 光学活性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、表示装置
US5587392A (en) 1994-05-27 1996-12-24 Mochida Pharmaceutical Co., Ltd. Azolyl methyl phenyl derivatives having aromatase inhibitory activity
ES2169102T3 (es) 1994-10-14 2002-07-01 Merck Patent Gmbh (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
JP3802581B2 (ja) 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
JPH08325154A (ja) 1995-03-31 1996-12-10 Mitsui Toatsu Chem Inc 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼａ２阻害剤
DE19534209A1 (de) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonales Mittel zur Behandlung der Haut
AU713236B2 (en) 1996-02-15 1999-11-25 Sankyo Company Limited Diarly alkane derivatives containing an alicyclic group, their preparation and their theraputic and prophylactic uses
ES2127106B1 (es) * 1996-03-21 1999-11-16 Menarini Lab Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
DE19612032A1 (de) 1996-03-27 1997-10-09 Basf Ag Substituierte 1-Methyl-3-benzyluracile
JPH107647A (ja) 1996-06-25 1998-01-13 Yamanouchi Pharmaceut Co Ltd 新規なチオ尿素誘導体又はその塩
US5847166A (en) 1996-10-10 1998-12-08 Massachusetts Institute Of Technology Synthesis of aryl ethers
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
KR100513302B1 (ko) 1997-02-04 2005-11-11 동화약품공업주식회사 3-아미노-1,2-벤조이소옥사졸 유도체, 이의 제조방법및 용도
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
RU2192412C2 (ru) * 1997-09-18 2002-11-10 Басф Акциенгезельшафт Производные бензамидоксимов, промежуточные продукты, фунгицидные средства, способ борьбы с фитопатогенными грибами
US6297239B1 (en) 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2000034247A2 (de) 1998-12-04 2000-06-15 Basf Aktiengesellschaft Verfahren zur herstellung von pyrazolylbenzoylderivaten sowie neue pyrazolylbenzoylderivate
WO2000034269A1 (en) 1998-12-09 2000-06-15 American Home Products Corporation Thiourea inhibitors of herpes viruses
US6184249B1 (en) 1998-12-18 2001-02-06 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
GB9904786D0 (en) 1999-03-02 1999-04-28 Merck Sharp & Dohme Therapeutic agents
WO2000059888A1 (en) 1999-04-02 2000-10-12 Neurogen Corporation N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
US20020065303A1 (en) 2000-02-01 2002-05-30 Bing-Yan Zhu Bivalent phenylene inhibitors of factor Xa
JP5265838B2 (ja) 2000-07-13 2013-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング キラルな化合物ｉ
EE200300084A (et) 2000-08-31 2005-02-15 Pfizer Inc. Fenoksübensüülamiini derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
ES2321693T3 (es) * 2000-09-06 2009-06-10 Emisphere Technologies, Inc. Compuestos de acido cianofenoxi carboxilico y composiciones para la administracion de agentes activos.
NZ525630A (en) 2000-10-06 2004-10-29 Tanabe Seiyaku Co Nitrogen-containing 5-membered ring compound used as dipeptidylpeptidase IV (DPPIV) inhibitor
WO2002036734A2 (en) 2000-10-12 2002-05-10 Merck & Co., Inc. Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
ES2271124T3 (es) 2000-11-24 2007-04-16 Smithkline Beecham Plc Compuestos indolil-sulfonilicos utiles en el tratamiento de trastornos del snc.
AU2002236775A1 (en) 2001-01-16 2002-07-30 Seok-Ki Choi Sodium channel modulators
MXPA03006885A (es) 2001-01-31 2003-11-13 Pfizer Prod Inc Derivados de eteres utiles como agentes inhibidores de las isozimas pde4.
DE10110438A1 (de) 2001-03-05 2002-09-19 Bayer Ag Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
ES2283532T3 (es) 2001-04-10 2007-11-01 Pfizer, Inc. Derivados de pirazol para tratar el vih.
AR035700A1 (es) 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
DE10126434A1 (de) 2001-05-31 2002-12-05 Bayer Ag Thiochromenone
GB0202679D0 (en) 2002-02-05 2002-03-20 Glaxo Group Ltd Novel compounds
PT1480634E (pt) 2002-02-07 2011-10-12 Univ Tennessee Res Foundation Moduladores selectivos do receptor do androgénio (sarms) para o tratamento da hiperplasia benigna da próstata
TW200302722A (en) 2002-02-13 2003-08-16 Astrazeneca Ab Therapeutic agents
EP1474127B1 (en) * 2002-02-15 2006-11-15 Endorecherche, Inc. Biphenyl derivatives and their use as antiandrogenic agents
IL163742A0 (en) 2002-02-28 2005-12-18 Univ Tennessee Res Foundation Irreversible selective androgen receptor modulators and methods of use thereof
EP1490317A1 (en) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1348433A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC Thiazol-2-yl-imine compounds as PDE-7 inhibitors
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
DE10218963A1 (de) 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
US6875438B2 (en) * 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
US6951884B2 (en) * 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
DE60313874T8 (de) 2002-08-14 2008-03-27 Ciba Specialty Chemicals Holding Inc. Flüssigkristallanzeige und farbfilter mit verbesserter durchsichtigkeit für grünes licht
AU2003262805A1 (en) 2002-08-26 2004-03-11 Merck & Co., Inc. Acetophenone potentiators of metabotropic glutamate receptors
WO2004110994A1 (en) 2003-06-18 2004-12-23 Pfizer Products Inc. Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
FI20030958A0 (fi) 2003-06-27 2003-06-27 Orion Corp Uusia yhdisteitä
WO2006006065A1 (en) 2004-07-08 2006-01-19 Warner-Lambert Company Llc Androgen modulators
TW200708499A (en) * 2005-06-22 2007-03-01 Warner Lambert Co Process for producing ethers

Also Published As

Publication number Publication date
EA200601267A1 (ru) 2006-12-29
MA28361A1 (fr) 2006-12-01
AU2005214167A1 (en) 2005-09-01
TW200534842A (en) 2005-11-01
CR8555A (es) 2006-10-17
EA009902B1 (ru) 2008-04-28
AU2005214167B2 (en) 2008-08-07
JP3997255B2 (ja) 2007-10-24
KR20060116223A (ko) 2006-11-14
US20050182132A1 (en) 2005-08-18
UY28746A1 (es) 2005-09-30
AP2006003700A0 (en) 2006-08-31
PA8623501A1 (es) 2005-08-30
US7576128B2 (en) 2009-08-18
AR047606A1 (es) 2006-01-25
WO2005080320A1 (en) 2005-09-01
IL176935A0 (en) 2006-12-10
KR100783255B1 (ko) 2007-12-06
CA2554696A1 (en) 2005-09-01
BRPI0507670A (pt) 2007-07-17
PE20051168A1 (es) 2006-02-18
JP2007522199A (ja) 2007-08-09
CA2554696C (en) 2009-06-30
EP1716110A1 (en) 2006-11-02
ECSP066761A (es) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20064053L (no) Androgen reseptormodulatorer
DK2311464T3 (da) Midler til forebyggelse og behandling af lidelser, som involverer modulation af RyR-receptorerne
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
ATE473744T1 (de) Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren
TW200618817A (en) Diffractive colorants for cosmetics
EA200900202A1 (ru) Селективные модуляторы андрогенного рецептора, их аналоги и производные и их использование
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
NO20055516L (no) Kannabinoidreceptorligander og anvendelser derav
TW200621725A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
NO20081975L (no) Diarylamin-inneholdende forbindelser og sammensetninger, og deres anvendelse som modulatorer av C-kit-reseptorer
NO20081788L (no) Cyklopropylaminer som modulatorer av histamin-H3-reseptoren
NO20082170L (no) Forbedret testosterongel og fremgangsmate til anvendelse
ATE407122T1 (de) Azadecalinmodulatoren des glucocorticoidrezeptors
DK1799649T3 (da) 3-(2-hydroxyphenyl)-pyrazoler og deres anvendelse som hsp90-modulatorer
TW200621244A (en) Modulators of muscarinic receptors
TW200716088A (en) Formulations and methods for treating amyloidosis
TW200744567A (en) Phenylethylamine analogs and their use for treating glaucoma
NO20075801L (no) Fremgangsmate til a behandle eller forhindre bennedbrytning eller osteoporose
NO20093542L (no) Inhibering av tumormetastase ved hjelp av anti-neuropilin 2-antistoffer
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
NO20073369L (no) Modulatorer av muskarinreseptorer
NO20075321L (no) Fremgangsmate for bronnbehandling og konstruksjon
NO20076026L (no) Adrogenmodulatorer
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application